New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

Nune, Arvind; Durkowski, Victor; Sujitha Pillay, S.; Barman, Bhupen; Elwell, Helen; Bora, Kaustubh; Bilgrami, Syed; Mahmood, Sajid; Babajan, Nasarulla; Venkatachalam, Srinivasan; Ottewell, Lesley; Manzo, Ciro

doi:10.3390/vaccines11101571

Public

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

Published in Vaccines • Oct 8, 2023

Authors:

Arvind Nune

Victor Durkowski

S. Sujitha Pillay

Abstract

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs in adults following SARS-CoV-2 vaccinations....

Subject

Medicine

Tocilizumab

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!